Cabaletta Bio (CABA) Other financing activities (2019)
Cabaletta Bio's quarterly Other financing activities came in at $1.3 million in Q1 2019.
Cabaletta Bio has reported Other financing activities for 1 years, with the latest figure at $1.3 million in Q1 2019.
- For the quarter ending Q1 2019, Other financing activities changed N/A year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2019 stood at $1.3 million (changed N/A YoY), and the FY2019 full-year result was $1.3 million, up 665.09% from the prior year.
- Other financing activities for Q1 2019 stood at $1.3 million.
- The five-year high for Other financing activities was $1.3 million in Q1 2019, with the low at $1.3 million in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 1.29 Mn |
| Mar 31, 2019 | 1.29 Mn |